1857 Health Technology (Shenzhen) Co., Ltd., formerly known as Shenzhen Huayangsen Health Management Technology Co., Ltd., was incorporated in Shenzhen on September 20, 2024 as a Sino-foreign limited liability company with a registered capital of RMB 10 million. Headquartered in Nanshan District, Shenzhen, it serves as the exclusive industrial implementation and operation entity of the Asia-Pacific 1857 Microbiology Research Institute, undertaking responsibilities including research achievement commercialization, product marketization, brand operation and global channel management. Focusing on three core tracks—microecological biotechnology, medicinal and edible homologous fermentation engineering, and endogenous anti-aging functional food, the company deeply leverages the comprehensive research system of the Asia-Pacific 1857 Microbiology Research Institute to form a closed-loop full industrial chain covering fundamental mechanism research, strain fermentation process optimization, active ingredient extraction, formula development and product commercialization. Cutting-edge core technologies from the Research Institute deliver robust technical support to the company, including: the anaerobic co-fermentation system of nine strains of compound probiotics and 23 types of Chinese medicinal herbs, the telomere regulation and chronic inflammation intervention technology relying on ∂-57 active factor (molecular formula: C₂₉H₃₄O₈), patented microbial fermentation processes, and the sustained-release technology of highly active strains via microcapsule embedding. These technologies enable the compliant transformation of scientific research findings into consumer-grade and high-net-worth targeted functional dietary supplements. Taking advantage of the scientific and innovative geographical strengths of the Guangdong-Hong Kong-Macao Greater Bay Area centered on Shenzhen, the company adheres to the development philosophy of "rooted in scientific research, product-oriented development and compliance as the top priority". It continues to delve into the large health sector of microbe fermentation and medicinal-edible homologous functional products, advancing the industrialization, standardization and branding of microecological anti-aging technologies. The company strives to grow into a benchmark health technology enterprise in China for the commercialization of deep fermentation technical achievements of medicinal and edible homologous probiotics.